Cadila Pharmaceuticals Limited

Pharmaceutical company developing, manufacturing, and distributing drugs for 45+ therapeutic areas globally.

1991 | Ahmedabad, Gujarat (India) | Active
Last Updated:

Cadila Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 120.65 Cr
  • Paid Up Capital ₹ 80.01 Cr
  • Company Age 34 Year, 12 Days
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 3,792.11 Cr
  • Satisfied Charges ₹ 2,932.95 Cr
  • Revenue Growth -0.44%
  • Profit Growth -93.85%
  • Ebitda -70.08%
  • Net Worth 54.21%
  • Total Assets 40.81%

About Cadila Pharmaceuticals

Cadila Pharmaceuticals Limited (CPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 28 February 1991 and has a history of 34 years. Its registered office is in Ahmedabad, Gujarat, India.

The Corporate was formerly known as Cadila Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 120.65 Cr and a paid-up capital of Rs 80.01 Cr.

The company currently has active open charges totaling ₹3,792.11 Cr. The company has closed loans amounting to ₹2,932.95 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Cadila Pharmaceuticals Limited India are Kamlesh Shah as CFO and Renuka Upadhyay as Company Secretary. Parul Shah, Abhijat Sheth, Rajiv Modi, and Four other members serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24231GJ1991PLC015132

  • Company No.

    015132

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    28 Feb 1991

  • Date of AGM

    25 Aug 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

What products or services does Cadila Pharmaceuticals Limited offer?

Cadila Pharmaceuticals Limited offers a wide range of products and services, including Health Conditions, Cold & Cough, Skin Care, Mosquito Repellents, Facewash, Respiratory Care, Sunscreen Products, Pain Relief, Women Care, Mother Care.

Who are the key members and board of directors at Cadila Pharmaceuticals?

Executive Team (3)

NameDesignationAppointment DateStatus
Rajiv Modi Country flag representing In Managing Director28-Feb-1991Current
Kamlesh Shah Country flag representing In CFO22-Dec-2022Current
Renuka Upadhyay Company Secretary16-Aug-2024Current

Board Members (6)

NameDesignationAppointment DateStatus
Parul Shah Country flag representing In Director 16-Apr-2024Current
Abhijat Sheth Country flag representing In Director 31-Aug-2018Current
Girdhar Balwani Country flag representing In Director 01-May-2017Current
Ramesh Choksi Country flag representing In Whole-Time Director 07-Feb-2014Current
Rajiv Modi Country flag representing Us Director 16-Aug-2024Current
Manvantkumar Rami Country flag representing In Director 16-Apr-2024Current

Financial Performance of Cadila Pharmaceuticals.

Cadila Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.44% decrease. The company also saw a substantial fall in profitability, with a 93.85% decrease in profit. The company's net worth Soared by an impressive increase of 54.21%.

Cadila Pharmaceuticals revenue growth over time
Cadila Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-0.44%
Revenue from Operations
-0.92%
Total Assets
40.81%
Profit or Loss
-93.85%
Net Worth
54.21%
EBITDA
-70.08%

What is the Ownership and Shareholding Structure of Cadila Pharmaceuticals?

In 2023, Cadila Pharmaceuticals had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹3,792.11 Cr

Satisfied Charges

₹2,932.95 Cr

Charges Breakdown by Lending Institutions

  • Others : 3014.35 Cr
  • Canara Bank : 300.00 Cr
  • Bank Of India : 200.00 Cr
  • Axis Bank Limited : 153.58 Cr
  • Hdfc Bank Limited : 124.18 Cr

Latest Charge Details

DateLenderAmountStatus
15 Apr 2024Others₹1,569.35 CrOpen
29 Sep 2023Canara Bank₹300.00 CrOpen
27 Jun 2023Hdfc Bank Limited₹63.75 CrOpen
23 Jun 2023Bank Of India₹100.00 CrOpen
24 Mar 2023Axis Bank Limited₹153.58 CrOpen

How Many Employees Work at Cadila Pharmaceuticals?

Cadila Pharmaceuticals has a workforce of 5833 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Cadila Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cadila Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cadila Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Cadila Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Rajiv Rajiv Modi was appointed as a Director was appointed as a Director on 16 Aug 2024 & has been associated with this company since 6 months 26 days .

  • Director Appointment

    Renuka Anjanikumar Upadhyay was appointed as a Company Secretary was appointed as a Company Secretary on 16 Aug 2024 & has been associated with this company since 6 months 26 days .

  • Charges

    A charge with Hdfc Bank Limited of Rs. 63.75 Cr registered on 27 Jun 2023 with Charge ID 100748963 was modified on 13 Jun 2024.

  • Charges

    A charge with Axis Bank Limited of Rs. 153.58 Cr registered on 24 Mar 2023 with Charge ID 100704145 was modified on 06 Jun 2024.

  • Charges

    A charge registered on 25 Jun 2021 via Charge ID 100460336 with Axis Bank Limited was fully satisfied on 16 May 2024.

  • Charges

    A charge with Others of Rs. 1,569.35 Cr registered on 15 Apr 2024 with Charge ID 100916122 was modified on 22 Apr 2024.

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Cadila Pharmaceuticals Limited?

    Cadila Pharmaceuticals Limited was incorporated on 28 Feb 1991.

  • What is authorized share capital and paid-up capital of Cadila Pharmaceuticals Limited?

    The authorized share capital of Cadila Pharmaceuticals Limited is ₹ 120.65 Cr and paid-up capital is ₹ 80.01 Cr.

  • Who are the current board members & directors of Cadila Pharmaceuticals Limited?

    Currently 9 directors are associated with Cadila Pharmaceuticals Limited.

    • Parul Nikunj Shah
    • Abhijat Chandrakant Sheth
    • Rajiv Indravadan Modi
    • Girdhar Prem Balwani
    • Ramesh Ratilal Choksi
    • Rajiv Rajiv Modi
    • Manvantkumar Shankerlal Rami
    • Kamlesh Navaratnalal Shah
    • Renuka Anjanikumar Upadhyay

  • What is the registered address of Cadila Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Cadila Pharmaceuticals Limited is Cadila Corporate Campus Sarkhej Dholka Road, Bhat India, Ahmedabad, Gujarat, 382210.

  • What is the corporate identification number (CIN) and company number of Cadila Pharmaceuticals Limited?

    The corporate identification number (CIN) of Cadila Pharmaceuticals Limited is U24231GJ1991PLC015132 and the company number is 015132 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Cadila Pharmaceuticals Limited?

    The Official website of Cadila Pharmaceuticals Limited is https://www.cadilapharma.com

  • What has been the recent revenue trend for Cadila Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Cadila Pharmaceuticals Limited has fallen by -0.44%.

  • How many employees does Cadila Pharmaceuticals Limited currently have?

    As Per 2023 financial reports, 5833 employees are currently employed by Cadila Pharmaceuticals Limited.

  • What change has been observed in the net worth of Cadila Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Cadila Pharmaceuticals Limited has experienced an upsurge of 54.21%.

  • What are the total open charges for Cadila Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Cadila Pharmaceuticals Limited amount to ₹ 3,792.11 Cr.

  • When was the last Balance Sheet of Cadila Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Cadila Pharmaceuticals Limited was filed with the ROC on 31 Mar 2023.

People also Viewed